Xellera Therapeutics houses Hong Kong’s first multi-product cGMP facility, designed with Grade A/B cleanrooms and integrated QC, R&D, and process development labs. Engineered for adaptable, scalable production, the facility supports clinical through commercial stages while meeting US FDA, EMA, PIC/S, and HK DoH standards. https://www.xelleratherapeutics.com/facilities/